Nevertheless, recent studies in patients with other forms of inflammatory liver diseases have not shown benefit of anti-TNF agents [44-47] or IL-10 [48-50], and the use of any of these agents would likely increase the risk of infections. The gene discussed is TNF; the disease is liver disorder.